DNMT1 and ovarian cancer: We hypothesized that up-regulation of miR-148a and miR-152 by treatment with 5-Aza and TSA could reverse cisplatin resistance through DNMT1 suppression in ovarian cancer and miR-148a and miR-152 down-regulation might be due to DNA methylation and histone de-acetylation.